Armodafinil vs modafinil?

Question

Accepted Answer

Armodafinil vs. Modafinil: A Quick Reference Guide

Feature	Modafinil (Provigil®)	Armodafinil (Nuvigil®)
Chemical composition	Racemic mixture (R‑ and S‑enantiomers)	Only the R‑enantiomer (active form)
Mechanism of action	Dopamine reuptake inhibition + activation of orexin & histamine pathways	Same as modafinil (R‑enantiomer drives most activity)
Approved uses	Narcolepsy, shift‑work sleep disorder, obstructive sleep apnea (OSA)	Same indications as modafinil
Typical dose (adult)	200 mg/day (single dose)	150 mg/day (single dose)
Half‑life	12–15 h	15–19 h (slightly longer)
Peak plasma concentration	~2–4 h after dosing	~2–5 h after dosing
Metabolism	CYP3A4 & CYP2C19; forms active metabolites (e.g., modafinil N‑oxide)	Primarily CYP3A4/3A5; fewer metabolites
Side‑effect profile	Headache, nausea, dry mouth, insomnia, anxiety, dizziness	Same as modafinil; similar or slightly lower incidence of nausea
Drug interactions	Strong CYP3A4 inducer (e.g., carbamazepine); reduced by strong CYP3A4 inhibitors (e.g., ketoconazole)	Same pattern; less susceptible to inhibition by CYP2C19 drugs
Special populations	Pregnancy category B; use with caution in liver disease	Same; slight caution in severe renal impairment
Cost & availability	Generic options widely available; lower cost	Less widely available; tends to be pricier

Enantiomers
- Modafinil contains both R‑ (active) and S‑ (less active) enantiomers.
- Armodafinil contains only the R‑enantiomer, which is responsible for the bulk of wakefulness promotion.
Potency & Duration
- Because it is “pure” R‑enantiomer, armodafinil has a slightly longer duration of action and may achieve comparable wakefulness at a lower dose.
- Studies show similar efficacy for narcolepsy and shift‑work disorders, with modest benefits of armodafinil in maintaining alertness over a full 24‑h period.

Narcolepsy – to reduce excessive daytime sleepiness.
Shift‑work Sleep Disorder – to improve alertness during night‑shift work.
Obstructive Sleep Apnea (OSA) – when sleep apnea is treated with CPAP, these drugs reduce residual daytime sleepiness.
Off‑label uses (reported but not FDA‑approved) – ADHD, depression, mild cognitive impairment, and even as “cognitive enhancers” in healthy adults.

Note: Always use under medical supervision; these agents can worsen certain psychiatric conditions (e.g., bipolar disorder, psychosis).

Titration: Start at the lowest dose; increase by 50 mg (modafinil) or 25 mg (armodafinil) every 1–2 weeks if needed.
Meal Interaction: Food increases absorption for modafinil; for armodafinil the effect is less pronounced but still best taken on an empty stomach or with a light meal.

Modafinil
- First‑order kinetics; saturation not reached at therapeutic doses.
- Metabolized mainly by CYP3A4 (major pathway) and CYP2C19 (minor).
- Excreted 70–80 % unchanged via kidneys; 20–30 % as metabolites.
Armodafinil
- Similar overall profile; metabolism mainly CYP3A4/3A5 with fewer active metabolites.
- Longer half‑life leads to less fluctuation in plasma concentration.

Symptom	Modafinil	Armodafinil
Headache	5–20 %	3–15 %
Nausea	1–10 %	1–7 %
Insomnia	1–8 %	1–6 %
Anxiety/irritability	2–9 %	1–6 %
Palpitations	1–3 %	1–2 %
Rare (1 % or less)	Hypertension, rash, visual disturbances	Similar

Long‑term safety remains under study. No evidence of dependency, but chronic use can mask underlying sleep disorders and lead to sleep debt.

Strong CYP3A4 inducers (e.g., carbamazepine, rifampin) → ↓ drug levels → reduced efficacy.
Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) → ↑ drug levels → increased side‑effects.
CYP2C19 inhibitors (e.g., fluconazole) → minimal effect on modafinil but slight effect on armodafinil.
Other stimulants (e.g., amphetamines, methylphenidate) → additive CNS stimulation; risk of tachycardia, hypertension.
Alcohol – may reduce alerting effect; avoid during treatment.

Factor	Modafinil	Armodafinil
Generic availability	Widely available in many countries	Limited generics; usually brand‑only in U.S.
Cost	Lower due to generics	Higher; sometimes reimbursed by insurers
Side‑effect profile	Similar overall	Slightly lower GI complaints
Duration of action	~12 h	~15 h (better for 24‑h shifts)
Dose adjustment in renal impairment	Reduce dose by half if CrCl <30 mL/min	Reduce dose similarly; caution if CrCl <15 mL/min
Pregnancy	Category B; use only if benefits outweigh risks	Same; avoid in pregnancy unless absolutely necessary

Effectiveness: Both drugs are similarly effective for narcolepsy, shift‑work sleep disorder, and residual daytime sleepiness in OSA.
Duration: Armodafinil’s longer half‑life may give a smoother wakefulness profile, especially for night‑shift workers.
Side Effects: Comparable; armodafinil may cause slightly fewer GI complaints.